Leprosy post-exposure prophylaxis: innovation and precision public health

Lancet Glob Health. 2021 Jan;9(1):e8-e9. doi: 10.1016/S2214-109X(20)30512-X.

Authors

Milton Ozório Moraes¹, Nádia Cristina Düppre²

Affiliations

¹ Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-360, Brazil. Electronic address: milton.moraes@fiocruz.br.
² Leprosy Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-360, Brazil.

PMID: 33338461
DOI: 10.1016/S2214-109X(20)30512-X

No abstract available

Publication types

Comment

MeSH terms

Feasibility Studies
Humans
Leprosy* / epidemiology
Leprosy* / prevention & control
Post-Exposure Prophylaxis
Public Health
Rifampin*

Substances

Rifampin